当前位置: X-MOL 学术Cytopathology › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Impact of rapid on-site evaluation in expediting the fast investigative lung cancer pathway
Cytopathology ( IF 1.3 ) Pub Date : 2023-12-06 , DOI: 10.1111/cyt.13345
Andrew Fowell 1 , Kashif Khan 1
Affiliation  

EBUS-TBNA is a method of acquiring tissue samples from intrathoracic lymph nodes and central intrathoracic tumours in patients suspected of having lung cancer. Rapid on-site evaluation (ROSE) denotes assessing tissue samples during EBUS (or bronchoscopy), providing instant feedback on sample adequacy and provisional cytomorphological diagnosis. Sector multidisciplinary team (MDT) discussion can then make informed treatment decisions, with confirmatory immunohistochemistry being finalised before provision of final treatment. Currently, impact of ROSE on length of time patients spend on the lung cancer diagnostic pathway remains unclear.

中文翻译:

快速现场评估对加快肺癌快速调查途径的影响

EBUS-TBNA 是一种从疑似肺癌患者的胸内淋巴结和中央胸内肿瘤获取组织样本的方法。快速现场评估 (ROSE) 是指在 EBUS(或支气管镜检查)期间评估组织样本,提供有关样本充足性和临时细胞形态学诊断的即时反馈。然后,部门多学科团队 (MDT) 讨论可以做出明智的治疗决策,并在提供最终治疗之前完成验证性免疫组织化学检查。目前,ROSE 对患者在肺癌诊断途径上花费的时间长度的影响仍不清楚。
更新日期:2023-12-06
down
wechat
bug